⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

May 21, 2025ACS Medicinal Chemistry LettersOpen Access

Novel Desamide Isotryptamine Tetracycles as 5-HT2C Agonists for Treating Brain Disorders

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

High Resolution Image Download MS PowerPoint Slide Provided herein are novel desamide isotryptamine tetracycles as 5-HT2C agonists, pharmaceutical compositions, use of such compounds in treating brain disorders, and processes for preparing such compounds.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ram W. Sabnis (2025) studied this question.

synapsesocial.com/papers/6a63037c4f5ef41b946a9203 https://doi.org/10.1021/acsmedchemlett.5c00286

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Will the Revolution Be Cyclized?: Using Macrocyclic Peptides to Deliver Oligonucleotides ExtrahepaticalyACS Medicinal Chemistry Letters · 2026
2Exploring Five-Membered S -Heterocyclic Scaffolds As Novel CaMKIIα Ligands Targeting the Hub DomainACS Medicinal Chemistry Letters · 2026
3The Discovery of Ulacamten, a Cardiac Myosin Inhibitor for the Treatment of Heart Failure with Preserved Ejection FractionACS Medicinal Chemistry Letters · 2026
4Discovery of N -Acyl Pyrimidine-Biphenyl Small-Molecule PD-L1 Inhibitors that Restore T Cell Function and Suppress Tumor Growth in Breast CancerACS Medicinal Chemistry Letters · 2026
5Design, Synthesis, and Biological Evaluations of Constrained Ugi Adducts as Anti-JEV AgentsACS Medicinal Chemistry Letters · 2026
6Synthesis and Evaluation of Mevalonate Diphosphate Analogs as Butyrophilin 3A3 LigandsACS Medicinal Chemistry Letters · 2026
7Discovery and In Vitro Characterization of Macrocyclic 2-(Heteroaryl)Pyrimidine Inhibitors Targeting Wild-Type KRAS and G12D/G12V MutantsACS Medicinal Chemistry Letters · 2026
8Direct STAT6 Inhibition Converts a Cytokine Signaling Hub into a Drug TargetACS Medicinal Chemistry Letters · 2026
9Novel Triazolopyrimidine Analogs as Glucosylceramide Synthase InhibitorsACS Medicinal Chemistry Letters · 2026
10Pyridazino-Indoles as Phenol Bioisosteres for Potent Inhibition of NLRP3ACS Medicinal Chemistry Letters · 2026

More from ACS Medicinal Chemistry Letters